A neat site demonstrating correlation does not equal causation.
For example:
US spending on science, space, and technology correlates with Suicides by hanging, strangulation and suffocation
Link: Spurious Correlations.
A neat site demonstrating correlation does not equal causation.
For example:
Link: Spurious Correlations.
Outbreaks of foodborne diseases carried by bacteria can be a nuisance at best, and deadly at worst. Researchers are looking into novel ways to keep food safe. One way to destroy these pathogens is with more pathogens.
Bacteriophages are viruses that specifically attack bacteria. These phages, as researchers call them, have evolved alongside bacteria and become very good at what they do.
Scientists are most interested in lytic phages – viruses that inject their DNA into a bacterium and then hijack the cell’s machinery to make new copies of the virus. The copies eventually burst through bacterium’s membrane, killing it, and attack neighboring cells.
…
Phages are a hopeful alternative. “Phage therapy was the big thing in the [19]20s and 30s,” said Jason Gill, a microbiologist at Texas A&M University in College Station, who was not involved in the study.
Biopreservation encompasses a number of food-preservation strategies, ranging from ancient methods such as fermentation to modern technologies including bacteriocins and bacteriophages.
In U.S. food industries today, biopreservation can be defined as the use of non-pathogenic microorganisms that antagonize or inhibit the growth of undesirable pathogenic and/or spoilage microbes through their metabolic activity or capacity to compete for nutrients or attachment niches, or the use of chemical compounds that have been fermented and then purified.
Our discussion here will be limited to biopreservation incorporating the use of microorganisms that inhibit, inactivate or antagonize other microorganisms.
Biopreservation methods can be used to enhance food safety by complementing other food-preservation processes, and due to their gentle nature can be used in situations where harsher treatments are undesirable, such as in fresh or minimally processed foods.
Link: Fighting microbes with microbes | 2014-03-05 | National Provisioner.
The sight of just one boot coming through the doorway cues the clatter of tiny hoofs as 500 piglets scramble away from Mike Male. “That’s the sound of healthy pigs,” shouts Male, a veterinarian who has been working on pig farms for more than 30 years. On a hot June afternoon, he walks down the central aisle of a nursery in eastern Iowa, scoops up a piglet and dangles her by her hind legs. A newborn piglet’s navel is an easy entry point for bacterial infections, he explains. If this pig were infected, she would have an abscess, a lump of inflamed tissue, just below the navel. “In human terms, she’d be an outie instead of an innie,” he says, rubbing the pig’s healthy, pink belly button.
Nearly six years ago, an outbreak of ‘outies’ at this nursery marked the first known infection with methicillin-resistant Staphylococcus aureus (MRSA) in pigs in the United States. MRSA has troubled hospitals around the world for more than four decades and has been infecting people outside of health-care settings since at least 1995 (see Nature 482, 23–25; 2012). It causes around 94,000 infections and 18,000 deaths annually in the United States. In the European Union, more than 150,000 people are estimated to contract MRSA each year. Its first appearance on a US farm signalled the expansion of what many believe is a dangerous source of human infection.
At the 2013 World Dairy Expo competition, the apple fell real close to the tree. The Grand Champion trophy went to a cloned cow named KHW Regiment Apple-3-Red-ETN, while second place went to her genetically identical source material, the original Apple-Red-ET.
The winner’s owner, a then-17-year-old named Tyler Faber, came from a singular genetic strain himself — his father was president of Trans Ova Genetics, a company in the business of cloning cows. The judges hadn’t known about the clonage, but later claimed it broke no rules (it may be that science progressed faster than the 4-H judging handbook).
The global epidemic of multidrug-resistant Salmonella Typhimurium DT104 provides an important example, both in terms of the agent and its resistance, of a widely disseminated zoonotic pathogen. Here, with an unprecedented national collection of isolates collected contemporaneously from humans and animals and including a sample of internationally derived isolates, we have used whole-genome sequencing to dissect the phylogenetic associations of the bacterium and its antimicrobial resistance genes through the course of an epidemic. Contrary to current tenets supporting a single homogeneous epidemic, we demonstrate that the bacterium and its resistance genes were largely maintained within animal and human populations separately and that there was limited transmission, in either direction. We also show considerable variation in the resistance profiles, in contrast to the largely stable bacterial core genome, which emphasizes the critical importance of integrated genotypic data sets in understanding the ecology of bacterial zoonoses and antimicrobial resistance.
Science | Sources of Antimicrobial Resistance (Perspective)
Science | Distinguishable Epidemics of Multidrug-Resistant Salmonella Typhimurium DT104 in Different Hosts
In case you missed it, Oct. 7–13 was designated Naturopathic Medicine Week, according to a Senate resolution sponsored by Sen. Barbara Mikulski and passed by the Senate with unanimous consent. Among the reasons the Senate cited:
Mikulski and the rest of the Senate may be surprised to learn that they were repeating 60-year-old justifications of Chinese medicine put forward by Chairman Mao. Unlike Mikulski, however, Mao was under no illusion that Chinese medicine—a key component of naturopathic education—actually worked. In The Private Life of Chairman Mao, Li Zhisui, one of Mao’s personal physicians, recounts a conversation they had on the subject. Trained as an M.D. in Western medicine, Li admitted to being baffled by ancient Chinese medical books, especially their theories relating to the five elements. It turns out his employer also found them implausible.
Link: Slate.com | Traditional Chinese medicine origins: Mao invented it but didn’t believe in it..
This report, Antibiotic resistance threats in the United States, 2013 gives a first-ever snapshot of the burden and threats posed by the antibiotic-resistant germs having the most impact on human health.
Each year in the United States, at least 2 million people become infected with bacteria that are resistant to antibiotics and at least 23,000 people die each year as a direct result of these infections. Many more people die from other conditions that were complicated by an antibiotic-resistant infection.
Antibiotic-resistant infections can happen anywhere. Data show that most happen in the general community; however, most deaths related to antibiotic resistance happen in healthcare settings such as hospitals and nursing homes.
In the pageant of life, we are genetically bloated. The human genome contains around 20,000 protein-coding genes. Many other species get by with a lot less. The gut microbe Escherichia coli, for example, has just 4,100 genes.
Scientists have long wondered how much further life can be stripped down and still remain alive. Is there a genetic essence of life? The answer seems to be that the true essence of life is not some handful of genes, but coexistence.
E. coli has fewer genes than we do, in part because it has a lot fewer things to do. It doesn’t have to build a brain or a stomach, for example. But E. coli is a versatile organism in its own right, with genes allowing it to feed on many different kinds of sugar, as well as to withstand stresses like starvation and heat.
In recent years, scientists have systematically shut down each of E. coli’s genes to see which it can live without. Most of its genes turn out to be dispensable. Only 302 have proved to be absolutely essential.
For desperately ill patients with serious, life-threatening antibiotic-resistant infections, access to new antibiotics is a matter of life and death.
All across America, people are dying from bacterial infections that we used to be able to cure with antibiotics.
Just this March, the Centers for Disease Control and Prevention warned the public about a four-fold increase in one group of “nightmare bacteria,” carbapenem-resistant Enterobacteriaceae, which kills up to 50% of the people infected, and is on the rise. The annual impact of antibiotic resistant infections on the U.S. health care system is estimated to be $21 billion to $34 billion in excess health care costs and more than 8 million additional hospital days. At the same time, we are not making new antibiotics fast enough to prevent these deaths.
Without new antibiotics, things we all take for granted, including surgery, chemotherapy, organ transplantation and premature infant care, will be in jeopardy. A streamlined but targeted approach that speeds regulatory approval of new antibiotics — and limits their use to the sickest of the sick — is an appropriate way to balance the safety risks of these new drugs with the lifesaving benefits they can offer patients who have no other treatment options.
Full editorial: Opinion: We need more new antibiotics – CNN.com.
See also: IDSA New antibiotics report; IDSA Limited Population Antibacterial Drug Proposal